Health ❯ Pharmaceuticals

Drug Discovery

Therapeutics Antibiotics Clinical Trials Bioactive Compounds Quantum Applications AI in Drug Development Research and Development Chemical Reactions AI in Healthcare Antimicrobial Agents Antimalarial Drugs Innovative Technologies Membrane Proteins Targeted Therapy Biotechnology Natural Products Molecular Screening Personalized Medicine Quantum Computing Applications Antibiotic Development Clinical Applications Research Studies Combination Therapy Treatment Development Clinical Development Compounds Antibiotic Resistance AI in Drug Discovery Targeted Therapies Therapeutics Development Repurposing Drugs Molecular Interactions

Nvidia, Eli Lilly Commit Up to $1 Billion for Bay Area AI Drug Discovery Lab

The plan centers on a closed-loop system tying AI models to automated wet labs to generate high-quality training data.

IonQ Claims 99.99% Two-Qubit Gate Fidelity in New Papers, Sending Shares Higher

Molecular 'Magnifying Glass' Flags Early Protein Aggregation in Living Cells

2025 Lasker-DeBakey Award Honors Scientists Behind Trikafta’s Cystic Fibrosis Breakthrough

Emory Revamps Chan–Evans–Lam Reaction to Expand Access to Vinylic Ethers

Peer-Reviewed OU Study Maps Amylin Receptors, Offering Tools for Next‑Gen Obesity Drugs

Cryo-EM Reveals LptM’s Key Role in Stabilizing Bacterial LptDE Complex

Minor Splicing Inhibition Yields Drug Leads for KRAS-Driven Cancers

Denmark’s QuNorth Secures €80 Million to Build Magne Quantum Computer

Nvidia Partners with Swedish Consortium to Build Country’s Biggest Enterprise AI Supercomputer

Researchers Identify Broad-Spectrum Inhibitors for Malaria Parasite's Key Protein Family